Pengcheng Luo
- Biochemistry top 2%
- Endocrinology, Diabetes and Metabolism top 10%
- Molecular Biology
- Pathology and Forensic Medicine
- Pollution top 10%
- Co-authors
- Lili LiChristophe MorisseauLikun GaoCong‐Yi WangMong-Heng WangBruce D. HammockJames M. LutherKai Zhu
- Topics
- Eicosanoids and Hypertension Pharmacology (5 papers)Cancer-related molecular mechanisms research (4 papers)Hormonal Regulation and Hypertension (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Pengcheng Luo
27 papers receiving 527 citations
Peers
Comparison fields: 5 of 76
- Biochemistry 200
- Endocrinology, Diabetes and Metabolism 159
- Molecular Biology 131
- Pathology and Forensic Medicine 84
- Pollution 71
Countries citing papers authored by Pengcheng Luo
This map shows the geographic impact of Pengcheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Luo more than expected).
Fields of papers citing papers by Pengcheng Luo
This network shows the impact of papers produced by Pengcheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Luo. The network helps show where Pengcheng Luo may publish in the future.
Co-authorship network of co-authors of Pengcheng Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Pengcheng Luo. A scholar is included among the top collaborators of Pengcheng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengcheng Luo. Pengcheng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 58 | |
| 8 | 3 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 11 | |
| 14 | 42 | |
| 15 | 24 | |
| 16 | 39 | |
| 17 | Disruption of Propofol's Therapeutic Window by the Ingredients from Malaytea scurfpea Fruit | 1 |
| 18 | 31 | |
| 19 | 59 | |
| 20 | 102 |
About Pengcheng Luo
Pengcheng Luo is a scholar working on Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 532 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (5 papers), Cancer-related molecular mechanisms research (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Biochemistry (200 citations), Endocrinology, Diabetes and Metabolism (159 citations) and Pollution (71 citations). Pengcheng Luo has collaborated with scholars based in China and United States. Frequent co-authors include Lili Li, Christophe Morisseau, Likun Gao, Cong‐Yi Wang, Mong-Heng Wang, Bruce D. Hammock, James M. Luther, Kai Zhu, Hsin-Hsin Chang and Chen Chen. Their work appears in journals such as Scientific Reports, The FASEB Journal and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.